Asia: Blood-Grouping Reagents Market 2024

Blood-Grouping Reagents Market Size in Asia

The Asian blood-grouping reagents market contracted to $X in 2022, shrinking by -10.6% against the previous year. Over the period under review, consumption continues to indicate a relatively flat trend pattern. Over the period under review, the market reached the maximum level at $X in 2016; however, from 2017 to 2022, consumption remained at a lower figure.

Blood-Grouping Reagents Production in Asia

In value terms, blood-grouping reagents production dropped to $X in 2022 estimated in export price. Overall, production, however, recorded a relatively flat trend pattern. The growth pace was the most rapid in 2013 with an increase of 35% against the previous year. The level of production peaked at $X in 2016; however, from 2017 to 2022, production remained at a lower figure.

Blood-Grouping Reagents Exports

Exports in Asia

In 2022, overseas shipments of blood-grouping reagents decreased by -12.8% to X tons for the first time since 2019, thus ending a two-year rising trend. Over the period under review, exports, however, recorded a perceptible increase. The growth pace was the most rapid in 2016 when exports increased by 89%. Over the period under review, the exports reached the maximum at X tons in 2021, and then declined in the following year.

In value terms, blood-grouping reagents exports reduced to $X in 2022. Overall, exports, however, saw buoyant growth. The pace of growth appeared the most rapid in 2020 when exports increased by 77% against the previous year. The level of export peaked at $X in 2021, and then reduced in the following year.

Exports by Country

India (X tons) and South Korea (X tons) were the major exporters of blood-grouping reagents in 2022, recording near 33% and 24% of total exports, respectively. Singapore (X tons) ranks next in terms of the total exports with an 8.8% share, followed by China (7.3%), Turkey (7.2%) and the United Arab Emirates (4.8%). Israel (X tons) followed a long way behind the leaders.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the key exporting countries, was attained by Turkey (with a CAGR of +45.6%), while the other leaders experienced more modest paces of growth.

In value terms, the largest blood-grouping reagents supplying countries in Asia were India ($X), South Korea ($X) and Singapore ($X), with a combined 62% share of total exports. Turkey, Israel, the United Arab Emirates and China lagged somewhat behind, together comprising a further 27%.

Among the main exporting countries, Turkey, with a CAGR of +40.2%, saw the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

The export price in Asia stood at $X per ton in 2022, remaining relatively unchanged against the previous year. Export price indicated a resilient increase from 2012 to 2022: its price increased at an average annual rate of +6.0% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, blood-grouping reagents export price decreased by -11.5% against 2020 indices. The pace of growth appeared the most rapid in 2015 an increase of 54% against the previous year. As a result, the export price attained the peak level of $X per ton. From 2016 to 2022, the export prices remained at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Israel ($X per ton), while India ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the United Arab Emirates (+7.3%), while the other leaders experienced more modest paces of growth.

Blood-Grouping Reagents Imports

Imports in Asia

In 2022, overseas purchases of blood-grouping reagents were finally on the rise to reach X tons for the first time since 2018, thus ending a three-year declining trend. Over the period under review, imports, however, recorded a slight contraction. The most prominent rate of growth was recorded in 2014 when imports increased by 45% against the previous year. As a result, imports attained the peak of X tons. From 2015 to 2022, the growth of imports remained at a somewhat lower figure.

In value terms, blood-grouping reagents imports expanded to $X in 2022. In general, imports continue to indicate a relatively flat trend pattern. The growth pace was the most rapid in 2014 with an increase of 33%. The level of import peaked at $X in 2020; however, from 2021 to 2022, imports stood at a somewhat lower figure.

Imports by Country

In 2022, China (X tons), distantly followed by Saudi Arabia (X tons), Japan (X tons), Turkey (X tons), Thailand (X tons) and the Philippines (X tons) were the main importers of blood-grouping reagents, together constituting 69% of total imports. Kuwait (X tons), India (X tons), Cyprus (X tons), Singapore (X tons), Indonesia (X tons), the United Arab Emirates (X tons) and Israel (X tons) held a relatively small share of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the key importing countries, was attained by Kuwait (with a CAGR of +25.7%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest blood-grouping reagents importing markets in Asia were China ($X), Saudi Arabia ($X) and Japan ($X), with a combined 58% share of total imports. Kuwait, India, Thailand, Turkey, Singapore, the United Arab Emirates, Israel, Indonesia, Cyprus and the Philippines lagged somewhat behind, together comprising a further 30%.

Kuwait, with a CAGR of +20.3%, recorded the highest growth rate of the value of imports, among the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in Asia stood at $X per ton in 2022, remaining constant against the previous year. Import price indicated pronounced growth from 2012 to 2022: its price increased at an average annual rate of +2.3% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, blood-grouping reagents import price decreased by -3.1% against 2020 indices. The growth pace was the most rapid in 2018 an increase of 19%. Over the period under review, import prices attained the maximum at $X per ton in 2020; however, from 2021 to 2022, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Kuwait ($X per ton), while the Philippines ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the Philippines (+7.2%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :